SOLUTIONS
Start with one valuable outcome. Build from there.
VED combines senior drug-development judgement, specialist execution and AI assurance. The first engagement is deliberately focused; the operating relationship grows only when it creates measurable value.
VED working method
- 01Decide
- 02Deliver
- 03Compound
THE VED MODEL
Three connected capabilities
Each capability stands alone. Together they create a practical operating model for lean biotech teams and life-sciences technology companies.
Drug Development Decision Lab
Resolve high-stakes clinical, regulatory and evidence questions with a senior-led, time-boxed process.
Explore 02 / PEOPLEExperts & Talent
Deploy a fractional leader, a focused project pod or the right permanent hire against a clearly defined capability gap.
Explore 03 / AIRegulatoryX AI Assurance
Evaluate life-sciences AI with domain experts and introduce controlled, traceable AI workflows into regulated R&D.
ExploreCOMMERCIAL ENTRY POINTS
Buy a defined result—not an open-ended consultancy
Programme Decision Sprint
An evidence-backed decision memo, risk map and 90-day action plan for one consequential programme question.
Explore 6–10 WEEKSHealth-Authority Sprint
Meeting strategy, questions, positions, briefing direction, rehearsal and advice implementation.
Explore MONTHLYFractional R&D Leadership
Senior ownership of a regulatory or cross-functional development workstream without a full-time build.
Explore 4–6 WEEKSAI Evaluation or Workflow Pilot
A bounded evaluation or controlled workflow with domain rubrics, human review and measurable acceptance criteria.
Explore SCOPE-BASEDExpert Pod or Search
A named team to own a deliverable—or a focused search for a pivotal permanent leader.
ExploreHOW WE SCALE
Service revenue today. Reusable intelligence tomorrow.
Every assignment follows a common operating discipline: define the decision, structure the evidence, deploy the right experts, capture the approved rationale and improve the workflow. Client-confidential information remains protected; reusable methods are built from permissioned, de-identified patterns and public sources.
- Founder-led work establishes trust and produces near-term revenue
- Expert pods add delivery capacity without imitating a full-service CRO
- Structured templates, rubrics and issue taxonomies improve each engagement
- RegulatoryX can mature into benchmark, evaluation and workflow products after repeated paid use
Start with the constraint
What must your programme decide, prove or deliver next?
Share the situation, evidence and timing. We will propose the smallest credible first step.